We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$896M
AUM Growth
+$146M
Cap. Flow
+$110M
Cap. Flow %
12.31%
Top 10 Hldgs %
19.26%
Holding
130
New
4
Increased
114
Reduced
5
Closed
7

Sector Composition

Rank Sector Weight
1 Industrials 21.71%
2 Technology 19.05%
3 Financials 14.42%
4 Healthcare 14.13%
5 Consumer Discretionary 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MATW icon
26
Matthews International
MATW
$866M
$10.7M 1.19%
174,350
+28,449
+19% +$1.86M
AEL
27
DELISTED
American Equity Investment Life Holding Company
AEL
$10.6M 1.19%
405,155
+69,055
+21% +$1.68M
CAMP
28
DELISTED
CalAmp Corp.
CAMP
$9.97M 1.11%
21,325
+4,743
+29% +$2.01M
MRCY icon
29
Mercury Systems
MRCY
$5.76B
$9.52M 1.06%
226,261
-20,661
-8% -$812K
CUBI icon
30
Customers Bancorp
CUBI
$2.65B
$9.3M 1.04%
328,727
+18,303
+6% +$541K
CMCO icon
31
Columbus McKinnon
CMCO
$596M
$9.22M 1.03%
362,604
+17,035
+5% +$441K
MODV
32
DELISTED
ModivCare
MODV
$9.22M 1.03%
182,125
+21,205
+13% +$975K
EPAY
33
DELISTED
Bottomline Technologies Inc
EPAY
$9.14M 1.02%
355,636
+58,558
+20% +$1.44M
WWE
34
DELISTED
World Wrestling Entertainment
WWE
$9.05M 1.01%
444,124
+76,869
+21% +$1.59M
REI icon
35
Ring Energy
REI
$315M
$8.85M 0.99%
680,962
+21,015
+3% +$262K
QDEL icon
36
QuidelOrtho
QDEL
$1.13B
$8.74M 0.97%
321,871
+15,184
+5% +$376K
SP
37
DELISTED
SP Plus Corporation
SP
$8.71M 0.97%
285,194
+14,291
+5% +$444K
CRL icon
38
Charles River Laboratories
CRL
$11.3B
$8.71M 0.97%
86,096
+19,168
+29% +$1.76M
BBT
39
Beacon Financial Corp
BBT
$2.57B
$8.64M 0.96%
245,729
+41,407
+20% +$1.49M
OPB
40
DELISTED
Opus Bank Common Stock
OPB
$8.62M 0.96%
356,164
+67,517
+23% +$1.49M
PBH icon
41
Prestige Consumer Healthcare
PBH
$2.37B
$8.58M 0.96%
162,444
+25,840
+19% +$1.38M
TCF
42
DELISTED
TCF Financial Corporation Common Stock
TCF
$8.38M 0.94%
173,166
+31,439
+22% +$1.5M
UMPQ
43
DELISTED
Umpqua Holdings Corp
UMPQ
$8.32M 0.93%
453,324
+80,406
+22% +$1.43M
GWR
44
DELISTED
Genesee & Wyoming Inc.
GWR
$8.3M 0.93%
121,347
+27,471
+29% +$1.81M
MRT
45
DELISTED
MedEquities Realty Trust, Inc.
MRT
$8.23M 0.92%
652,064
+75,408
+13% +$903K
FFBC icon
46
First Financial Bancorp
FFBC
$3.55B
$8.13M 0.91%
293,376
+53,721
+22% +$1.44M
SLRC icon
47
SLR Investment Corp
SLRC
$696M
$8.04M 0.9%
367,766
+77,670
+27% +$1.71M
PACW
48
DELISTED
PacWest Bancorp
PACW
$8.01M 0.89%
171,445
+26,794
+19% +$1.31M
WAB icon
49
Wabtec
WAB
$49.4B
$7.96M 0.89%
86,947
+9,058
+12% +$755K
CAI
50
DELISTED
CAI International, Inc.
CAI
$7.95M 0.89%
337,029
+15,869
+5% +$316K

Similar funds

Aristotle Capital Boston's Q2 2017 Portfolio in Review

As of Q2 2017, Aristotle Capital Boston held 130 positions worth $896M, up 20% from $750M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Aristotle Capital Boston deployed $110M of net new capital in Q2 2017, opening 4 new positions and adding to 114 existing holdings. Its largest new stake was Green Bancorp, Inc: 113,056 shares worth $2.19M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, down from 22% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Novanta, an estimated $2.54M trimmed.

  • Aristotle Capital Boston's largest Q2 2017 buy was Green Bancorp, Inc: 113,056 shares worth $2.19M.
  • Aristotle Capital Boston added most to Everforth Inc in Q2 2017, an estimated $3.43M increase.
  • Aristotle Capital Boston's biggest Q2 2017 reduction was Novanta, cutting an estimated $2.54M.
  • Aristotle Capital Boston fully exited PrivateBancorp Inc in Q2 2017, selling an estimated $12.6M.
  • Aristotle Capital Boston's ten largest holdings make up 19% of its $896M portfolio in Q2 2017.
  • Aristotle Capital Boston opened 4 new positions and closed 7 in Q2 2017.
  • Aristotle Capital Boston's portfolio value rose 20% quarter-over-quarter to $896M.

Based on Aristotle Capital Boston's 13F filing for Q2 2017, filed 14 Aug 2017.